Allogene Therapeutics (ALLO) Shareholding Patterns
$0.62
As on 20-Nov-2026 16:00EST
Market cap
$291 Mln
Revenue (TTM)
$5 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
$0.62
As on 20-Nov-2026 16:00EST
Market cap
$291 Mln
Revenue (TTM)
$5 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %